4.5 Article

Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial

David W. Dodick et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Medicine, General & Internal

Fremanezumab for the Preventive Treatment of Chronic Migraine

Stephen D. Silberstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Physiology

PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING

Peter J. Goadsby et al.

PHYSIOLOGICAL REVIEWS (2017)

Review Pharmacology & Pharmacy

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date

Lanfranco Pellesi et al.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)

Review Clinical Neurology

TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine

Sarah Walter et al.

CURRENT PAIN AND HEADACHE REPORTS (2015)

Review Health Care Sciences & Services

Systematic Review of Migraine Prophylaxis Adherence and Persistence

Zsolt Hepp et al.

JOURNAL OF MANAGED CARE PHARMACY (2014)